{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:46:20Z","timestamp":1793094380930,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1245\/s10434-024-15814-8","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T13:01:37Z","timestamp":1721480497000},"page":"7229-7236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Adjuvant Systemic Therapy Improved Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma"],"prefix":"10.1245","volume":"31","author":[{"given":"Francesco","family":"Di Bello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia Maria Ippolita","family":"Jannello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Siech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"de Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natali","family":"Rodriguez Pe\u00f1aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Coll\u00e0","family":"Ruvolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Creta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Morra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"de Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix K. H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Puliatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"key":"15814_CR1","unstructured":"EAU Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma - INTRODUCTION - Uroweb. Uroweb - European Association of Urology. https:\/\/uroweb.org\/guidelines\/upper-urinary-tract-urothelial-cell-carcinoma. Accessed 3 July 2022."},{"issue":"8","key":"15814_CR2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","volume":"20","author":"TW Flaig","year":"2022","unstructured":"Flaig TW, Spiess PE, Abern M, et al. NCCN Guidelines\u00ae insights: bladder cancer, version 2.2022. J Natl Compr Cancer Netw. 2022;20(8):866\u201378. https:\/\/doi.org\/10.6004\/jnccn.2022.0041.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"10232","key":"15814_CR3","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","volume":"395","author":"A Birtle","year":"2020","unstructured":"Birtle A, Johnson M, Chester J, et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. 2020;395(10232):1268\u201377. https:\/\/doi.org\/10.1016\/S0140-6736(20)30415-3.","journal-title":"Lancet"},{"key":"15814_CR4","doi-asserted-by":"publisher","first-page":"17674","DOI":"10.1038\/s41598-020-74940-x","volume":"10","author":"Y Luo","year":"2020","unstructured":"Luo Y, Feng B, Wei D, et al. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity. Sci Rep. 2020;10:17674. https:\/\/doi.org\/10.1038\/s41598-020-74940-x.","journal-title":"Sci Rep"},{"issue":"1","key":"15814_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","volume":"68","author":"C Kwak","year":"2006","unstructured":"Kwak C, Lee SE, Jeong IG, Ku JH. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology. 2006;68(1):53\u20137. https:\/\/doi.org\/10.1016\/j.urology.2006.01.053.","journal-title":"Urology"},{"issue":"7","key":"15814_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1442-2042.2004.00841.x","volume":"11","author":"S Suzuki","year":"2004","unstructured":"Suzuki S, Shinohara N, Harabayashi T, Sato S, Abe T, Koyanagi T. Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer. Int J Urol. 2004;11(7):456\u201360. https:\/\/doi.org\/10.1111\/j.1442-2042.2004.00841.x.","journal-title":"Int J Urol"},{"issue":"7","key":"15814_CR7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.ejso.2018.12.004","volume":"45","author":"S Nazzani","year":"2019","unstructured":"Nazzani S, Mazzone E, Preisser F, et al. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma. Eur J Surg Oncol. 2019;45(7):1238\u201345. https:\/\/doi.org\/10.1016\/j.ejso.2018.12.004.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"15814_CR8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","volume":"35","author":"T Seisen","year":"2017","unstructured":"Seisen T, Krasnow RE, Bellmunt J, et al. Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma. J Clin Oncol. 2017;35(8):852\u201360. https:\/\/doi.org\/10.1200\/JCO.2016.69.4141.","journal-title":"J Clin Oncol"},{"key":"15814_CR9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01659","author":"AJ Birtle","year":"2024","unstructured":"Birtle AJ, Jones R, Chester J, et al. Improved disease-free survival with adjuvant chemotherapy after nephroureterectomy for upper tract urothelial cancer: final results of the POUT trial. J Clin Oncol. 2024. https:\/\/doi.org\/10.1200\/JCO.23.01659.","journal-title":"J Clin Oncol"},{"issue":"6","key":"15814_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.urolonc.2016.11.018","volume":"35","author":"A Cohen","year":"2017","unstructured":"Cohen A, Kuchta K, Park S. Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma. Urol Oncol. 2017;35(6):322\u20137. https:\/\/doi.org\/10.1016\/j.urolonc.2016.11.018.","journal-title":"Urol Oncol"},{"issue":"1","key":"15814_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of tumours of the urinary system and male genital organs-part b: prostate and bladder tumours. Eur Urol. 2016;70(1):106\u201319. https:\/\/doi.org\/10.1016\/j.eururo.2016.02.028.","journal-title":"Eur Urol"},{"issue":"5","key":"15814_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.euo.2020.11.005","volume":"4","author":"C Coll\u00e0 Ruvolo","year":"2021","unstructured":"Coll\u00e0 Ruvolo C, Nocera L, Stolzenbach LF, et al. Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma. Eur Urol Oncol. 2021;4(5):792\u2013801. https:\/\/doi.org\/10.1016\/j.euo.2020.11.005.","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"15814_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.euf.2021.03.003","volume":"8","author":"C Coll\u00e0 Ruvolo","year":"2022","unstructured":"Coll\u00e0 Ruvolo C, Nocera L, Stolzenbach LF, et al. Tumor size predicts muscle-invasive and non-organ-confined disease in upper tract urothelial carcinoma at radical nephroureterectomy. Eur Urol Focus. 2022;8(2):498\u2013505. https:\/\/doi.org\/10.1016\/j.euf.2021.03.003.","journal-title":"Eur Urol Focus"},{"key":"15814_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102105","author":"S Morra","year":"2024","unstructured":"Morra S, Scheipner L, Baudo A, et al. Unmarried status effect on stage at presentation and treatment patterns in non-metastatic upper tract urothelial carcinoma patients. Clin Genitourin Cancer. 2024. https:\/\/doi.org\/10.1016\/j.clgc.2024.102105.","journal-title":"Clin Genitourin Cancer"},{"key":"15814_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16333","author":"M de Angelis","year":"2024","unstructured":"de Angelis M, Baudo A, Siech C, et al. Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer. BJU Int. 2024. https:\/\/doi.org\/10.1111\/bju.16333.","journal-title":"BJU Int"},{"key":"15814_CR16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15228-6","author":"C Siech","year":"2024","unstructured":"Siech C, Baudo A, de Angelis M, et al. Perioperative complications and in-hospital mortality in partial and radical nephrectomy patients with heart-valve replacement. Ann Surg Oncol. 2024. https:\/\/doi.org\/10.1245\/s10434-024-15228-6.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"15814_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.eururo.2020.04.008","volume":"78","author":"G Califano","year":"2020","unstructured":"Califano G, Xylinas E. Re: phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma. Eur Urol. 2020;78(1):113\u20134. https:\/\/doi.org\/10.1016\/j.eururo.2020.04.008.","journal-title":"Eur Urol"},{"issue":"5","key":"15814_CR18","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00345-020-03502-7","volume":"39","author":"G Califano","year":"2021","unstructured":"Califano G, Ouzaid I, Verze P, Hermieu JF, Mirone V, Xylinas E. Immune checkpoint inhibition in upper tract urothelial carcinoma. World J Urol. 2021;39(5):1357\u201367. https:\/\/doi.org\/10.1007\/s00345-020-03502-7.","journal-title":"World J Urol"},{"key":"15814_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.euros.2020.10.003","volume":"22","author":"TR Dob\u00e9","year":"2020","unstructured":"Dob\u00e9 TR, Califano G, von Rundstedt FC, et al. Postoperative chemotherapy bladder instillation after radical nephroureterectomy: results of a European survey from the Young Academic Urologist Urothelial Cancer Group. Eur Urol Open Sci. 2020;22:45\u201350. https:\/\/doi.org\/10.1016\/j.euros.2020.10.003.","journal-title":"Eur Urol Open Sci"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15814-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15814-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15814-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T14:27:33Z","timestamp":1726756053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15814-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["15814"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15814-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,20]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}